Fahad Almohareb

1.3k total citations
41 papers, 404 citations indexed

About

Fahad Almohareb is a scholar working on Hematology, Genetics and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Fahad Almohareb has authored 41 papers receiving a total of 404 indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Hematology, 13 papers in Genetics and 11 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Fahad Almohareb's work include Acute Lymphoblastic Leukemia research (10 papers), Hematopoietic Stem Cell Transplantation (8 papers) and Hemoglobinopathies and Related Disorders (8 papers). Fahad Almohareb is often cited by papers focused on Acute Lymphoblastic Leukemia research (10 papers), Hematopoietic Stem Cell Transplantation (8 papers) and Hemoglobinopathies and Related Disorders (8 papers). Fahad Almohareb collaborates with scholars based in Saudi Arabia, United States and France. Fahad Almohareb's co-authors include Mahmoud Aljurf, Hazzaa Alzahrani, Mohamad Mohty, Naeem Chaudhri, Sayer Al-harbi, Fahad Alsharif, Amr Nassar, Ahmad Al-Ghamdi, Khalid Ahmed Al‐Anazi and Mouhab Ayas and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Ophthalmology.

In The Last Decade

Fahad Almohareb

35 papers receiving 396 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Fahad Almohareb Saudi Arabia	10	181	116	80	76	74	41	404
Thierry Fagot France	9	241 1.3×	188 1.6×	72 0.9×	145 1.9×	90 1.2×	21	515
Akihito Shinohara Japan	13	221 1.2×	66 0.6×	61 0.8×	65 0.9×	9 0.1×	43	493
M. D. Hamon United Kingdom	7	188 1.0×	36 0.3×	24 0.3×	104 1.4×	22 0.3×	8	428
Günther Dannecker Germany	15	58 0.3×	55 0.5×	19 0.2×	79 1.0×	56 0.8×	48	481
Bernd Gmeinhart Austria	7	209 1.2×	28 0.2×	37 0.5×	22 0.3×	37 0.5×	8	360
F Schooneman France	10	89 0.5×	158 1.4×	19 0.2×	32 0.4×	17 0.2×	51	417
Gerard J. Ventura United States	9	299 1.7×	33 0.3×	75 0.9×	73 1.0×	8 0.1×	16	415
Heike Bialleck Germany	13	343 1.9×	50 0.4×	102 1.3×	37 0.5×	8 0.1×	16	643
Sadaya Matano Japan	12	92 0.5×	20 0.2×	67 0.8×	40 0.5×	7 0.1×	43	388
Sara Mastaglio Italy	11	148 0.8×	37 0.3×	29 0.4×	168 2.2×	11 0.1×	34	724

Countries citing papers authored by Fahad Almohareb

Since Specialization

Citations

This map shows the geographic impact of Fahad Almohareb's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fahad Almohareb with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fahad Almohareb more than expected).

Fields of papers citing papers by Fahad Almohareb

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fahad Almohareb. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fahad Almohareb. The network helps show where Fahad Almohareb may publish in the future.

Co-authorship network of co-authors of Fahad Almohareb

This figure shows the co-authorship network connecting the top 25 collaborators of Fahad Almohareb. A scholar is included among the top collaborators of Fahad Almohareb based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fahad Almohareb. Fahad Almohareb is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Al-Judaibi, Bandar, Hazzaa Alzahrani, Ali Alahmari, et al.. (2025). Emerging need for a hepato-hematology program for patients with sickle cell disease in Saudi Arabia. Saudi Journal of Gastroenterology. 31(2). 53–58.

Al‐Jefri, Abdullah, Ahmad S. Alotaibi, Mansour Alfayez, et al.. (2024). First Description of New Variant of Germline ERCC6L2 Mutations Causing Bone Marrow Failure, a Single Center Report of 11 Cases in 7 Families. Blood. 144(Supplement 1). 5706–5706.

Alahmari, Ali, Gamal Mohamed, Ammar Alkawi, et al.. (2024). Posterior reversible encephalopathy syndrome post stem cell transplantation in sickle cell disease: case series and literature review. Frontiers in Medicine. 11. 1330688–1330688.

Fuente, Josu de la, Arnaud Dalissier, Mohsen Al Zahrani, et al.. (2024). Allogeneic Transplantation for Sickle Cell Disease Offers High Rates of Cure with Low Incidence of Severe Chronic GVHD in Both Children and Adults: Real World Data from 2010-2021. An Analysis of the European Society for Blood and Bone Marrow Transplantation Hemoglobinopathy Working Party. Blood. 144(Supplement 1). 176–176.

Almohareb, Fahad, et al.. (2021). Pregnancy with Paroxysmal Nocturnal Hemoglobinuria: A Case Series with Review of the Literature. SHILAP Revista de lepidopterología. 9(2). 178–189. 5 indexed citations

Hanbali, Amr, Riad El Fakih, Feras Alfraih, et al.. (2021). Improved survival in adolescents and young adults (AYA) patients aged 14–55 years with acute lymphoblastic leukemia using pediatric-inspired protocol – a retrospective analysis of a real-world experience in 79 of patients treated at a national tertiary care referral center. SHILAP Revista de lepidopterología. 16. 100270–100270. 2 indexed citations

Fakih, Riad El, Walid Rasheed, Syed Osman Ahmed, et al.. (2021). The outcomes of secondary AML post allogeneic hematopoietic cell transplantation significantly depend on the presence of poor‐risk cytogenetic abnormalities. SHILAP Revista de lepidopterología. 2(2). 249–256. 1 indexed citations

Alahmari, Ali, Mahmoud Aljurf, Amal Al-Seraihy, et al.. (2020). Hematopoietic stem cell transplantation for patients with sickle cell disease in the Eastern Mediterranean. Hematology/Oncology and Stem Cell Therapy. 13(2). 106–110. 1 indexed citations

Iqbal, Madiha, Tea Reljic, Selim Corbacioglu, et al.. (2020). Systematic Review/Meta-Analysis on Efficacy of Allogeneic Hematopoietic Cell Transplantation in Sickle Cell Disease: An International Effort on Behalf of the Pediatric Diseases Working Party of European Society for Blood and Marrow Transplantation and the Sickle Cell Transplantation International Consortium. Transplantation and Cellular Therapy. 27(2). 167.e1–167.e12. 11 indexed citations

10.

Hanbali, Amr, Riad El Fakih, Feras Alfraih, et al.. (2019). Improved Outcome of a Pediatric-Inspired Protocol for High-Risk Adolescent and Young Adult Acute Lymphoblastic Leukemia Patients Using Peg-Asparaginase and Escalating Dose of Methotrexate: Tolerability and Outcome. Clinical Lymphoma Myeloma & Leukemia. 19(10). 670–677. 5 indexed citations

11.

Qureshi, Shoeb, et al.. (2019). The frequency and spectrum of HBB gene mutation in β-Thalassemia patients in Saudi Arabia. Journal of Natural Science Biology and Medicine. 10(1). 97–97. 2 indexed citations

12.

Fakih, Riad El, et al.. (2018). Azacitidine Use for Myeloid Neoplasms. Clinical Lymphoma Myeloma & Leukemia. 18(4). e147–e155. 6 indexed citations

13.

Chaudhri, Naeem, Mahmoud Aljurf, Fahad Almohareb, et al.. (2017). Establishing an autologous versus allogeneic hematopoietic cell transplant program in nations with emerging economies. Hematology/Oncology and Stem Cell Therapy. 10(4). 173–177. 6 indexed citations

14.

Alaiya, Ayodele, Mahmoud Aljurf, Zakia Shinwari, et al.. (2016). Protein signatures as potential surrogate biomarkers for stratification and prediction of treatment response in chronic myeloid leukemia patients. International Journal of Oncology. 49(3). 913–933. 17 indexed citations

15.

Cesaro, Simone, Marta Pillon, Gloria Tridello, et al.. (2012). Relationship between clinical and BK virological response in patients with late hemorrhagic cystitis treated with cidofovir: a retrospective study from the European Group for Blood and Marrow Transplantation. Bone Marrow Transplantation. 48(6). 809–813. 32 indexed citations

16.

Alzahrani, Hazzaa, Amr Nassar, Fahad Almohareb, et al.. (2010). Fludarabine-Based Conditioning Chemotherapy for Allogeneic Hematopoietic Stem Cell Transplantation in Acquired Severe Aplastic Anemia. Biology of Blood and Marrow Transplantation. 17(5). 717–722. 14 indexed citations

17.

Tabbara, Khalid F., Ahmad Al-Ghamdi, Fahad Almohareb, et al.. (2009). Ocular Findings after Allogeneic Hematopoietic Stem Cell Transplantation. Ophthalmology. 116(9). 1624–1629. 102 indexed citations

18.

Al‐Anazi, Khalid Ahmed, et al.. (2008). Klebsiella oxytoca bacteremia causing septic shock in recipients of hematopoietic stem cell transplant: Two case reports. Cases Journal. 1(1). 160–160. 7 indexed citations

19.

Al‐Anazi, Khalid Ahmed, et al.. (2007). Septic shock caused by Sphingomonas paucimobilis bacteremia in a patient with hematopoietic stem cell transplantation. Transplant Infectious Disease. 10(2). 142–144. 20 indexed citations

20.

Al-Momen, Abdulkareem, et al.. (1996). Granulocyte—Macrophage Colony—Stimulating Factor in Newly Diagnosed Adult Patients with Acute Lymphoblastic Leukemia Treated with Conventional Chemotherapy. Hematology. 1(3). 207–214. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact